• CoronaCoronavirus (COVID-19) Resources

    In an effort to support our members with the most updated information on COVID-19 we developed this resource page to easily access current CDC information and other resources to assist you professionally and personally.

    We will continue to update this page with more information as it becomes available and welcome your input as we navigate through this situation. As health care professionals it is our job to educate our patients and families on prevention and the what to do if someone is symptomatic.

    View resources


  • 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsGAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    Rescheduled, so you won't miss a thing! Find out what to do next!

    April 20-24, 2021, Honolulu, Hawaii

    More Information

  • AwardCall for Excellence Award Nominations

    The awards are: Emerging Chapter Award, Established Chapter Excellence Award, Special Interest Group Excellence Award, Excellence in Clinical Practice Award, Excellence in Community Service Award, Excellence in Education Award, Excellence in Leadership Award, and Excellence in Research Award.

    The nominations are tallied in July and the winners are announced every year during the Awards Celebration at the GAPNA Annual Conference.

    Now is the time to nominate a colleague or yourself - DEADLINE is June 1, 2020.

    Get started... nominate today!

  • FREE CE for GAPNA MembersFREE continuing education credit is available for the following session:

    "Safety and Utility of Cannabis in the Elderly"

    (session captured at the GAPNA 2018 Annual Conference)

    For March/April 2020 - Get Your Free CNE Now!

Risk of Death Increases in Nursing Home Residents After Exposure to Typical Antipsychotics

Older antipsychotic medications, called typical antipsychotics, can cause a variety of central nervous system side effects.

The newer, atypical agents are preferred by many due to their better side effect profiles. Typical antipsychotics can increase the risk for mortality in the elderly, conclude researchers.

Researchers analyzed Medicare and Medicaid data on 3,609 typical antipsychotic users matched with 3,609 atypical antipsychotic users. Residents who used atypical antipsychotics had an unadjusted mortality rate of 18.42% compared with 24.06% for users of typical antipsychotics. On average, there was a 41% higher risk of death within 180 days of exposure to typical agents compared to treatment with atypical agents.

The researchers advise physicians to base their decisions to use antipsychotics in this population on individual risk factors as well as the acute and long-term risks of therapy. Since dual-eligible residents are particularly vulnerable, they should be closely monitored once antipsychotic treatment is started.

For more info, see Aparasu et al. (2012). Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents. Medical Care, 50(11), 961-968. doi:10.1097/MLR.0b013e31826ec185

Related Topic 1: 

GAPNA Newsletter Issue: